相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Physical Activity Among Patients With Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-Related Restrictions
Yuan Lu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial
G. Michael Felker et al.
JAMA CARDIOLOGY (2022)
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
Gregory D. Lewis et al.
CIRCULATION-HEART FAILURE (2022)
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
John R. Teerlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF
John R. Teerlink et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Exercise Intolerance in Heart Failure With Preserved Ejection Fraction Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis
Nicholas E. Houstis et al.
CIRCULATION (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2016)
Cardiopulmonary Exercise Testing in Heart Failure
Rajeev Malhotra et al.
JACC-HEART FAILURE (2016)
Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data meta-analysis of randomized controlled trials
Francesco Giallauria et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Iron deficiency in chronic heart failure: An international pooled analysis
IJsbrand T. Klip et al.
AMERICAN HEART JOURNAL (2013)
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients Results From Heart Failure and a Controlled Trial to Investigate Outcomes of Exercise Training
Ann M. Swank et al.
CIRCULATION-HEART FAILURE (2012)
World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult-a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation
James C. Fang et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
John G. F. Cleland et al.
LANCET (2011)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Impact of Cardiac Contractility Modulation on Left Ventricular Global and Regional Function and Remodeling
Cheuk-Man Yu et al.
JACC-CARDIOVASCULAR IMAGING (2009)
Assessment of functional capacity in clinical and research settings - A scientific statement from the American heart association committee on exercise, rehabilitation, and prevention of the council on clinical cardiology and the council on cardiovascular nursing
Ross Arena et al.
CIRCULATION (2007)
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure
DW Kitzman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
